Summary:
David I. Lubetkin is conducting this research study to learn more about a new investigational,non-hormonal drug called elinzanetanttosee if it may reduce the number and severityof hot flashes in postmenopausal women. Overall, this study will consist of 11 visits to the study site and twophone visitsover a period of 15 months.
Qualified Participants Must:
- Be postmenopausal women between 40-65 years of age.
- Have moderate to severe hot flashes and be seeking treatment.
Qualified Participants May Receive:
Qualified Participants May Receive:
- No-cost investigational medication.
- No-cost study-related medical care.
- Compensation up to $1100.